Your browser doesn't support javascript.
loading
Reduced frequency of cytotoxic CD56dim CD16+ NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma.
Pánisová, Elena; Lünemann, Anna; Bürgler, Simone; Kotur, Monika; Lazarovici, Julien; Danu, Alina; Kaulfuss, Meike; Mietz, Juliane; Chijioke, Obinna; Münz, Christian; Busson, Pierre; Berger, Christoph; Ghez, David; Azzi, Tarik.
Afiliação
  • Pánisová E; Experimental Infectious Diseases and Cancer Research, University Children's Hospital of Zurich, Zurich, Switzerland.
  • Lünemann A; Children's Research Center, University Children's Hospital of Zurich, Zurich, Switzerland.
  • Bürgler S; Experimental Infectious Diseases and Cancer Research, University Children's Hospital of Zurich, Zurich, Switzerland.
  • Kotur M; Children's Research Center, University Children's Hospital of Zurich, Zurich, Switzerland.
  • Lazarovici J; Department of Neurology With Institute of Translational Neurology, University of Münster, Münster, Germany.
  • Danu A; Experimental Infectious Diseases and Cancer Research, University Children's Hospital of Zurich, Zurich, Switzerland.
  • Kaulfuss M; Children's Research Center, University Children's Hospital of Zurich, Zurich, Switzerland.
  • Mietz J; Experimental Infectious Diseases and Cancer Research, University Children's Hospital of Zurich, Zurich, Switzerland.
  • Chijioke O; Children's Research Center, University Children's Hospital of Zurich, Zurich, Switzerland.
  • Münz C; Department of Hematology, Gustave Roussy and Université Paris Saclay, Villejuif, France.
  • Busson P; Department of Hematology, Gustave Roussy and Université Paris Saclay, Villejuif, France.
  • Berger C; Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Ghez D; Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Azzi T; Cellular Immunotherapy, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Cancer Immunol Immunother ; 71(1): 13-24, 2022 Jan.
Article em En | MEDLINE | ID: mdl-33993319
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Hodgkin / Receptores de IgG / Antígeno CD56 / Anticorpos Tipo de estudo: Observational_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Hodgkin / Receptores de IgG / Antígeno CD56 / Anticorpos Tipo de estudo: Observational_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça